藍光發展(600466.SH):子公司嘉寶股份明日正式登陸港交所
格隆匯10月17日丨藍光發展(600466.SH)公佈,經中國證券監督管理委員會《關於核准四川藍光嘉寶服務集團股份有限公司發行境外上市外資股的批覆》核准,公司下屬控股子公司四川藍光嘉寶服務集團股份有限公司(以下簡稱“嘉寶股份”)已向香港聯交所主板遞交公開發行H股股票及上市申請並獲香港聯交所批准。
本次嘉寶股份共發行4291.62萬股(假設未行使超額配售權),發行完成後嘉寶股份總股本增加至1.72億股,公司間接持有嘉寶股份1.16億股,佔嘉寶股份發行完成後總股本的67.48%。嘉寶股份的股票預期將於2019年10月18日在香港聯交所主板上市交易,股票代碼為“02606.HK”,股票簡稱為“藍光嘉寶服務”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.